Ming-Sound Tsao

40PUBLICATIONS
269CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer cell biologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|May 13, 2026
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion.

|Mar 26, 2026
Preclinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report.

Nikolina Radulovich, Pamela Soberanis Pina, Molly L Udaskin

|Feb 06, 2026
METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers.

Xin Xu, Yujuan Wang, Helen Zhu

|Oct 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases.

Maisam Makarem, Tuan Hoang, Mitchell J Elliott

|Oct 11, 2025
Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms.

Joshua C Rosen, Pinjiang Cao, Nhu-An Pham

|Jul 12, 2025
Tumour- and Non-Tumour-Associated Factors That Modulate Response to PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer.

Maryam Khalil, Ming-Sound Tsao

Pageof 7

Frequent Collaborators

6 joint publications

Ni Liu

4 joint publications

Housheng Hansen He

4 joint publications

Nhu-An Pham

3 joint publications

Xin Xu